Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K23HL141596)
National Center for Advancing Translational Sciences (UL1TR002538)
Received: 2 February 2020
Accepted: 26 February 2020
First Online: 6 March 2020
Ethics approval and consent to participate
: The study was approved with a waiver of informed consent by the Institutional Review Board at the University of Utah.
: Not applicable.
: Dr. Tonna reports receiving a modest speaker’s fees from LivaNova for cardiac arrest.